Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-14 · accession 0001493152-22-032555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-15 | 2022-11-14 | IMMX | Morris Gabriel S | CFO, Dir | P - Purchase | $0.94 | +5,200 | 81.3K | +7% | +$4,888 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | P | A | 5,200 | $0.94 | 81,316 | D | — | — |